StockGlow

Gilead Sciences, Inc. (GILD34.SA)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

332.18-0.03%Healthcare
Compare GILD34.SA with
StockGlow Score
61
Leaning Bullish
BearishBullish
1 year ago+4.7%

The outlook

Gilead Sciences, Inc. currently reads as leaning bullish based on mixed vs its moving averages, 84% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range84% of the way from its 52-week low to high
Market cap
$824.85B
52-wk high
396.35
52-wk low
0.00
50-day avg
331.71
200-day avg
344.90
Trailing P/E
17.6

Similar stocks

AMGN34.SAAmgen Inc.$71.85+0.00%PFIZ34.SAPfizer Inc.$31.43-1.63%BMYB34.SABristol-Myers Squibb Company$323.60-0.04%ABBV34.SAAbbVie Inc.$82.00-3.57%BIIB34.SABiogen Inc.$172.75+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy